These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8593120)

  • 1. Low-density lipoprotein heterogeneity.
    Griffin BA
    Baillieres Clin Endocrinol Metab; 1995 Oct; 9(4):687-703. PubMed ID: 8593120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary and genetic effects on low-density lipoprotein heterogeneity.
    Krauss RM
    Annu Rev Nutr; 2001; 21():283-95. PubMed ID: 11375438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic epidemiology of low-density lipoprotein subclass phenotypes.
    Austin MA
    Ann Med; 1992 Dec; 24(6):477-81. PubMed ID: 1485942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
    Kwiterovich PO
    Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and environmental influences on LDL subclass phenotypes.
    Austin MA
    Clin Genet; 1994 Jul; 46(1 Spec No):64-70. PubMed ID: 7988081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein atherogenicity: an overview of current mechanisms.
    Griffin BA
    Proc Nutr Soc; 1999 Feb; 58(1):163-9. PubMed ID: 10343354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance.
    Austin MA; Hokanson JE; Brunzell JD
    Curr Opin Lipidol; 1994 Dec; 5(6):395-403. PubMed ID: 7712044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease.
    Austin MA; Hokanson JE
    Med Clin North Am; 1994 Jan; 78(1):99-115. PubMed ID: 8283937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atherogenicity of low-density lipoproteins (LDL). A problem of quantity or quality?].
    Dejager S; Turpin G
    Presse Med; 1995 Dec; 24(38):1772-6. PubMed ID: 8545426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-gene interactions in human lipoprotein metabolism.
    Dreon DM; Krauss RM
    J Am Coll Nutr; 1997 Aug; 16(4):313-24. PubMed ID: 9263180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype.
    Krauss RM
    World Rev Nutr Diet; 1997; 80():22-43. PubMed ID: 9069721
    [No Abstract]   [Full Text] [Related]  

  • 15. Dense low density lipoproteins and coronary artery disease.
    Krauss RM
    Am J Cardiol; 1995 Feb; 75(6):53B-57B. PubMed ID: 7863975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relation between insulin resistance and small, dense lipoproteins with low density and the development of atherosclerosis in type 2 diabetes mellitus].
    Fábryová L; Cagán S
    Bratisl Lek Listy; 1998; 99(3-4):138-45. PubMed ID: 9919742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenic lipoprotein phenotype and diet-gene interactions.
    Krauss RM
    J Nutr; 2001 Feb; 131(2):340S-3S. PubMed ID: 11160558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of low-density lipoprotein subclasses in children.
    Arisaka O; Fujiwara S; Yabuta K; Mokuno H; Mitugi Y; Miyake N
    Metabolism; 1997 Feb; 46(2):146-8. PubMed ID: 9030819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein density and atherosclerosis. Unraveling the connection.
    Slyper AH
    JAMA; 1994 Jul; 272(4):305-8. PubMed ID: 8028144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
    Rizzo M; Trepp R; Berneis K; Christ ER
    Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.